Logo
x

Search

Subscribe Now

Confo Therapeutics

Confo Therapeutics Entered into a Research Collaboration with AbCellera for GPCR-Targeting Antibody Discovery

Confo Therapeutics Entered into a Research Collaboration with AbCellera for GPCR-Targeting Antibody Discovery

  • June 15, 2023
Confo Therapeutics Entered into a Global License Agreement with Eli Lilly for CFTX-1554

Confo Therapeutics Entered into a Global License Agreement with Eli Lilly for CFTX-1554

  • March 2, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.